Skip to main content

Table 2 Cost effectiveness of HPV vaccination in Estonia, model estimates

From: The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia

  Discounted total Incremental
  Costs/person (€)* QALY/person (year)** Costs/person (€)* QALY/person (year)** Costs/QALYs (€/year)***
No vaccination 126.29 27.09184 -- -- --
Routine vaccination 152.79 27.09726 26.5 0.00542 4889
  1. *Costs rounded to 0.01; **QALYs rounded to 0.00001; ***Costs/QALYs rounded to 1.